Highlights
NASDAQ: ARGX       Argenx Se Ads
Last Price Today's Change   Day's Range   Trading Volume
125.37   -1.02 (0.81%)  124.15 - 125.80  134,500

Overview

 
Avg Volume (4 weeks):163,515
4 Weeks Range:121.52 - 137.82
4 Weeks Price Volatility (%):
23.62%
52 Weeks Range:63.85 - 150.92
52 Weeks Price Volatility (%):
70.66%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

argenx NV, formerly arGEN X BV is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

  Be the first to like this.
 


 

3389  4377  627  443 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MDR 2.01+0.43 
 BAC 29.59-0.23 
 SPY 298.28-2.80 
 CHK 1.58-0.06 
 EEM 41.61+0.04 
 AMD 30.05-0.24 
 XLF 28.08-0.31 
 NGD 1.17-0.06 
 T 37.91+0.76 
 GDX 28.69+0.59 
Partners & Brokers